APO RESEARCH · REPORT
Sepsis Treatment
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Product & engineering
Understand the product.
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Selected research
Industry Research
Sepsis Treatment Industry Research Report 2026
Market perspective
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.
Report Scope
Read the full market overview
This report quantifies the global Sepsis Treatment market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sepsis Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sepsis Treatment Market by Company
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
Allergan
Merck & Co
Asahi Kasei Corporation
AtoxBio
INOTREM
Adrenomed
Endacea
Sepsis Treatment Segment by Type
Cephalosporin
Pencillin
Macrolides
Others
Sepsis Treatment Segment by Application
Sepsis
Severe Sepsis
Septic Shock
Sepsis Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sepsis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sepsis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cephalosporin
- Pencillin
- Macrolides
- Others
Applications
- Sepsis
- Severe Sepsis
- Septic Shock
Companies covered
- Pfizer
- NCPC
- Bayer
- Shanghai Pharmaceuticals
- Johnson & Johnson
- Novartis
- GlaxoSmithKline
- TEVA
- Mylan
- Allergan
- Merck & Co
- Asahi Kasei Corporation
- AtoxBio
- INOTREM
- Adrenomed
- Endacea
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sepsis Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cephalosporin
- 2.2.3 Pencillin
- 2.2.4 Macrolides
- 2.2.5 Others
- 2.3 Sepsis Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Sepsis
- 2.3.3 Severe Sepsis
- 2.3.4 Septic Shock
- 2.4 Assumptions and Limitations
3 Sepsis Treatment Breakdown Data by Type
- 3.1 Global Sepsis Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Sepsis Treatment Forecasted Market Size by Type (2027-2032)
4 Sepsis Treatment Breakdown Data by Application
- 4.1 Global Sepsis Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Sepsis Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Sepsis Treatment Market Perspective (2021-2032)
- 5.2 Global Sepsis Treatment Growth Trends by Region
- 5.2.1 Global Sepsis Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Sepsis Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Sepsis Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Sepsis Treatment Market Dynamics
- 5.3.1 Sepsis Treatment Industry Trends
- 5.3.2 Sepsis Treatment Market Drivers
- 5.3.3 Sepsis Treatment Market Challenges
- 5.3.4 Sepsis Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Sepsis Treatment Players by Revenue
- 6.1.1 Global Top Sepsis Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Sepsis Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Sepsis Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Sepsis Treatment Head Office and Area Served
- 6.4 Global Sepsis Treatment Players, Product Type & Application
- 6.5 Global Sepsis Treatment Manufacturers Established Date
- 6.6 Global Sepsis Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Sepsis Treatment Market Size (2021-2032)
- 7.2 North America Sepsis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Sepsis Treatment Market Size by Country (2021-2026)
- 7.4 North America Sepsis Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Sepsis Treatment Market Size (2021-2032)
- 8.2 Europe Sepsis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Sepsis Treatment Market Size by Country (2021-2026)
- 8.4 Europe Sepsis Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Sepsis Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Sepsis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Sepsis Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Sepsis Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Sepsis Treatment Market Size (2021-2032)
- 10.2 South America Sepsis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Sepsis Treatment Market Size by Country (2021-2026)
- 10.4 South America Sepsis Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Sepsis Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Sepsis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Sepsis Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Sepsis Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer
- 12.1.1 Pfizer Company Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer Revenue in Sepsis Treatment Business (2021-2026)
- 12.1.4 Pfizer Sepsis Treatment Product Portfolio
- 12.1.5 Pfizer Recent Developments
- 12.2 NCPC
- 12.2.1 NCPC Company Information
- 12.2.2 NCPC Business Overview
- 12.2.3 NCPC Revenue in Sepsis Treatment Business (2021-2026)
- 12.2.4 NCPC Sepsis Treatment Product Portfolio
- 12.2.5 NCPC Recent Developments
- 12.3 Bayer
- 12.3.1 Bayer Company Information
- 12.3.2 Bayer Business Overview
- 12.3.3 Bayer Revenue in Sepsis Treatment Business (2021-2026)
- 12.3.4 Bayer Sepsis Treatment Product Portfolio
- 12.3.5 Bayer Recent Developments
- 12.4 Shanghai Pharmaceuticals
- 12.4.1 Shanghai Pharmaceuticals Company Information
- 12.4.2 Shanghai Pharmaceuticals Business Overview
- 12.4.3 Shanghai Pharmaceuticals Revenue in Sepsis Treatment Business (2021-2026)
- 12.4.4 Shanghai Pharmaceuticals Sepsis Treatment Product Portfolio
- 12.4.5 Shanghai Pharmaceuticals Recent Developments
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Information
- 12.5.2 Johnson & Johnson Business Overview
- 12.5.3 Johnson & Johnson Revenue in Sepsis Treatment Business (2021-2026)
- 12.5.4 Johnson & Johnson Sepsis Treatment Product Portfolio
- 12.5.5 Johnson & Johnson Recent Developments
- 12.6 Novartis
- 12.6.1 Novartis Company Information
- 12.6.2 Novartis Business Overview
- 12.6.3 Novartis Revenue in Sepsis Treatment Business (2021-2026)
- 12.6.4 Novartis Sepsis Treatment Product Portfolio
- 12.6.5 Novartis Recent Developments
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Company Information
- 12.7.2 GlaxoSmithKline Business Overview
- 12.7.3 GlaxoSmithKline Revenue in Sepsis Treatment Business (2021-2026)
- 12.7.4 GlaxoSmithKline Sepsis Treatment Product Portfolio
- 12.7.5 GlaxoSmithKline Recent Developments
- 12.8 TEVA
- 12.8.1 TEVA Company Information
- 12.8.2 TEVA Business Overview
- 12.8.3 TEVA Revenue in Sepsis Treatment Business (2021-2026)
- 12.8.4 TEVA Sepsis Treatment Product Portfolio
- 12.8.5 TEVA Recent Developments
- 12.9 Mylan
- 12.9.1 Mylan Company Information
- 12.9.2 Mylan Business Overview
- 12.9.3 Mylan Revenue in Sepsis Treatment Business (2021-2026)
- 12.9.4 Mylan Sepsis Treatment Product Portfolio
- 12.9.5 Mylan Recent Developments
- 12.10 Allergan
- 12.10.1 Allergan Company Information
- 12.10.2 Allergan Business Overview
- 12.10.3 Allergan Revenue in Sepsis Treatment Business (2021-2026)
- 12.10.4 Allergan Sepsis Treatment Product Portfolio
- 12.10.5 Allergan Recent Developments
- 12.11 Merck & Co
- 12.11.1 Merck & Co Company Information
- 12.11.2 Merck & Co Business Overview
- 12.11.3 Merck & Co Revenue in Sepsis Treatment Business (2021-2026)
- 12.11.4 Merck & Co Sepsis Treatment Product Portfolio
- 12.11.5 Merck & Co Recent Developments
- 12.12 Asahi Kasei Corporation
- 12.12.1 Asahi Kasei Corporation Company Information
- 12.12.2 Asahi Kasei Corporation Business Overview
- 12.12.3 Asahi Kasei Corporation Revenue in Sepsis Treatment Business (2021-2026)
- 12.12.4 Asahi Kasei Corporation Sepsis Treatment Product Portfolio
- 12.12.5 Asahi Kasei Corporation Recent Developments
- 12.13 AtoxBio
- 12.13.1 AtoxBio Company Information
- 12.13.2 AtoxBio Business Overview
- 12.13.3 AtoxBio Revenue in Sepsis Treatment Business (2021-2026)
- 12.13.4 AtoxBio Sepsis Treatment Product Portfolio
- 12.13.5 AtoxBio Recent Developments
- 12.14 INOTREM
- 12.14.1 INOTREM Company Information
- 12.14.2 INOTREM Business Overview
- 12.14.3 INOTREM Revenue in Sepsis Treatment Business (2021-2026)
- 12.14.4 INOTREM Sepsis Treatment Product Portfolio
- 12.14.5 INOTREM Recent Developments
- 12.15 Adrenomed
- 12.15.1 Adrenomed Company Information
- 12.15.2 Adrenomed Business Overview
- 12.15.3 Adrenomed Revenue in Sepsis Treatment Business (2021-2026)
- 12.15.4 Adrenomed Sepsis Treatment Product Portfolio
- 12.15.5 Adrenomed Recent Developments
- 12.16 Endacea
- 12.16.1 Endacea Company Information
- 12.16.2 Endacea Business Overview
- 12.16.3 Endacea Revenue in Sepsis Treatment Business (2021-2026)
- 12.16.4 Endacea Sepsis Treatment Product Portfolio
- 12.16.5 Endacea Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst